Literature DB >> 2983314

The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA.

K Fukuchi, A Tanaka, L W Schierman, R L Witter, M Nonoyama.   

Abstract

DNA of Marek disease virus (MDV) consists of two unique regions UL and US flanked by long inverted repeat regions TRL and IRL, and short inverted repeat regions TRS and IRS, respectively, similar to herpes simplex virus DNA. Comparison of restriction patterns between pathogenic and nonpathogenic MDV DNA was made to identify a region of viral DNA different between these two types of MDV, as it may be responsible for the tumorigenicity of MDV in chickens. The results indicated that BamHI-D and -H, located at the long inverted repeat regions TRL and IRL, were specifically expanded in nonpathogenic viral DNA. The location of the expanded region has been determined within 1.5 kilobase pairs of the Bgl I/Pst I fragment of BamHI-D and -H, close to the junction between the inverted repeat and the unique region. The possibility that a gene responsible for tumor induction may be disrupted by such expansion has been discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983314      PMCID: PMC397124          DOI: 10.1073/pnas.82.3.751

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Biological and biochemical properties of defective interfering particles of equine herpesvirus type 1.

Authors:  B E Henry; W W Newcomb; D J O'Callaghan
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Structure of Herpesvirus saimiri genomes: arrangement of heavy and light sequences in the M genome.

Authors:  G W Bornkamm; H Delius; B Fleckenstein; F J Werner; C Mulder
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

4.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

5.  Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.

Authors:  B H Rispens; H van Vloten; N Mastenbroek; H J Maas; K A Schat
Journal:  Avian Dis       Date:  1972-04       Impact factor: 1.577

6.  Studies on acute Marek's disease. I. Characteristics of isolate GA in chickens.

Authors:  C S Eidson; S C Schmittle
Journal:  Avian Dis       Date:  1968-08       Impact factor: 1.577

7.  The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture.

Authors:  A E Churchill; R C Chubb; W Baxendale
Journal:  J Gen Virol       Date:  1969-06       Impact factor: 3.891

8.  Attenuation of herpesvirus saimiri for marmosets after successive passage in cell culture at 39 degrees C.

Authors:  P A Schaffer; L A Falk; F Deinhardt
Journal:  J Natl Cancer Inst       Date:  1975-11       Impact factor: 13.506

9.  Transplantable Marek's disease lymphomas. I. Growth characteristics during development in two inbred lines of chickens.

Authors:  R M Coleman; L W Schierman
Journal:  Avian Dis       Date:  1982 Apr-Jun       Impact factor: 1.577

10.  Anatomy of herpes simplex virus DNA. VI. Defective DNA originates from the S component.

Authors:  N Frenkeĺ; H Locker; W Batterson; G S Hayward; B Roizman
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

View more
  36 in total

1.  The genome of turkey herpesvirus.

Authors:  C L Afonso; E R Tulman; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek's disease virus.

Authors:  F Peng; G Bradley; A Tanaka; G Lancz; M Nonoyama
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage.

Authors:  K Maotani; A Kanamori; K Ikuta; S Ueda; S Kato; K Hirai
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  A genomic map of infectious laryngotracheitis virus and the sequence and organization of genes present in the unique short and flanking regions.

Authors:  M A Wild; S Cook; M Cochran
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

6.  Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H.

Authors:  G Bradley; G Lancz; A Tanaka; M Nonoyama
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide.

Authors:  Y Hong; P M Coussens
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Retroviral insertional activation in a herpesvirus: transcriptional activation of US genes by an integrated long terminal repeat in a Marek's disease virus clone.

Authors:  D Jones; P Brunovskis; R Witter; H J Kung
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.

Authors:  E Le Rouzic; P Thoraval; M Afanassieff; Y Cherel; G Dambrine; B Perbal
Journal:  Mol Pathol       Date:  2002-08

10.  Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.

Authors:  Z Z Cui; L F Lee; J L Liu; H J Kung
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.